Advertisement

Mechanical Hemodynamic Support

  • Scott A. Schartel
  • Sheela S. Pai
Chapter

Abstract

Discuss the indications for intra-aortic balloon counterpulsation (IABC). Formulate a plan for the evaluation and management of ischemic limb complications related to IABC. Discuss the use of VAD therapy in the management of failing ventricular function. Compare and contrast a variety of VADs with regard to indications, contraindications, and complications. Discuss the technique of extracorporeal membrane oxygenation in the treatment of acute respiratory failure.

Keywords

Cardiogenic Shock Balloon Catheter Activate Partial Thromboplastin Time Balloon Inflation ECMO Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Kantrowitz A, Kantrowitz A. Experimental augmentation of coronary flow by retardation of the arterial pressure pulse. Surgery. 1953;34:678-687.PubMedGoogle Scholar
  2. 2.
    Kantrowicz A, Tjønneland S, Freed PS, Phillips SJ, Butner AN, Sherman JL. Initial clinical experience with intra-aortic balloon pumping in cardiogenic shock. JAMA. 1968;203:135-140.Google Scholar
  3. 3.
    Ferguson JJ, Cohen M, Freedman RJ, et al. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol. 2001;38:1456-1462.PubMedCrossRefGoogle Scholar
  4. 4.
    Kern MJ, Aguirre F, Bach R, Donohue T, Siegel R, Segal J. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation. 1993;87:500-511.PubMedCrossRefGoogle Scholar
  5. 5.
    Sanbron TA, Sleeper JA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK trial registry. J Am Coll Cardiol. 2000;36:1123-1129.CrossRefGoogle Scholar
  6. 6.
    Barron JV, Every NR, Parsons LS, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001;141:933-939.PubMedCrossRefGoogle Scholar
  7. 7.
    Stone GW, Marsalese D, Brodie BR, et al. A prospective, randomized evaluation of prophylactic intra-aortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol. 1997;29:1459-1467.PubMedCrossRefGoogle Scholar
  8. 8.
    Jiang CY, Zhao LL, Wnag JA, San J, Mohammod B. Anticoagulation therapy in intra-aortic balloon counterpulsation: does IABP really need anti-coagulation? J Zhejiang Univ Sci. 2003;4:607-611.PubMedCrossRefGoogle Scholar
  9. 9.
    Cohen M, Dawson MS, Kopinstansky C, McBride R. Sex and other predictors of intra-aortic balloon counterpulsation-related complications: prospective study of 1119 patients. Am Heart J. 2000;139:282-287.PubMedGoogle Scholar
  10. 10.
    Hazelrigg SR, Auer JE, Seifert PE. Experience in 100 transthoracic balloon pumps. Ann Thor Surg. 1992;54:528-532.CrossRefGoogle Scholar
  11. 11.
    Naunheim KS, Swartz MT, Pennington DG, et al. Intra-aortic balloon pumping in patients requiring cardiac operations: risk analysis and long-term follow-up. J Thor Cardiovasc Surg. 1992;104: 1654-1661.Google Scholar
  12. 12.
    Stavridis GT, O’Riordan JB. Paraplegia as a result of intra-aortic balloon counterpulsation. J Cardiovasc Surg. 1995;36:177-179.Google Scholar
  13. 13.
    Vonderheide RH, Thadhani R, Kuter DJ. Association of thrombocytopenia with the use of intra-aortic balloon pumps. Am J Med. 1998;105:27-32.PubMedCrossRefGoogle Scholar
  14. 14.
    BVS 5000 Quick Reference Guide, ABIOMED, Inc., Danvers, MA. Available from: http://www.abiomed.com/products/documents/BVS5000_Quick_Reference_Guide_I.pdf; 2006 Accessed 28.6.2008.
  15. 15.
    Dekkers RJ, FitzGerald DJ, Couper GS. Five-year clinical experience with Abiomed BVS 5000 as a ventricular assist device for cardiac failure. Perfusion. 2001;16:13-18.PubMedCrossRefGoogle Scholar
  16. 16.
    Guyton RA, Schonberger JPAM, Everts PAM, et al. Postcardiotomy shock: clinical evaluation of the BVS 5000 biventricular support system. Ann Thor Surg. 1993;56:346-356.CrossRefGoogle Scholar
  17. 17.
    AB5000 Ventricle: instructions for use. ABIOMED, Inc. Danvers, MA. Available from: http://www.abiomed.com/products/documents/0055_9001_rG.pdf; 2008 Accessed 29.6.2008.
  18. 18.
    AB500 ventricle training guide. ABIOMED, Inc. Danvers, MA. Available from: http://www.abiomed.com/products/documents/AB5000_Ventricle_Training_Guide_F.pdf; 2007 Accessed 29.6.2008.
  19. 19.
    HeartMate XVE LVAS Instructions for Use. Thoratec Corp. Pleasanton, CA. Available from: http://www.thoratec.com/medical-professionals/resource-library/ifus-manuals/heartmate-xve-lvad.aspx; 2006 Accessed 29.6.2008.
  20. 20.
    Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.PubMedCrossRefGoogle Scholar
  21. 21.
    Thoratec ventricular assist device (VAD) system: instructions for use. Thoratec Corporation, Pleasanton, CA. Available from: http://www.thoratec.com/_assets/download-tracker/Thor%20VAD%20IFU%2015003J%20ENGLISH.pdf; 2006 Accessed 4.7.2008.
  22. 22.
    Thoratec implantable ventricular assist device (IVAD): instructions for use. Thoratec Corporation. Pleasanton, CA; 2006; http://www.thoratec.com/medical-professionals/resource-library/ifus-manuals/thoratec-ivad.aspx Accessed 4.7.2008.
  23. 23.
    Slaughter MS, Tsui SS, El-Banayosy AE, et al. Results of a multicenter clinical trial with the Thoratec implantable ventricular assist device. J Thor Cardiovasc Surg. 2007;133:1573-1580e2.Google Scholar
  24. 24.
    Operator’s manual Novacor LVAS. World Heart, Inc., Oakland, CA. Available from: http://www.worldheart.com/products/manuals/novacor-lvas_manual.cfm; 2004 Accessed 4.7.2008.
  25. 25.
    Tsukui K, Abla A, Teuteberg JJ, et al. Cerebrovascular accidents in patients with a ventricular assist device. J Thor Cardiovasc Surg. 2007;134:114-123.CrossRefGoogle Scholar
  26. 26.
    Faggian G, Santini F, Franchi G, Portner PM, Mazzucco A. Insights from continued use of a Novacor left ventricular assist system for a period of 6 years. J Heart Lung Transplant. 2005;24:14444e17-1444e19.Google Scholar
  27. 27.
    HeartMate II LVAS operating manual. Thoratec Corporation. Pleasanton, CA. Available from: http://www.thoratec.com/medical-professionals/resource-library/ifus-manuals/heartmate-ll-lvad.aspx#levelFour; 2008 Accessed 4.7.2008.
  28. 28.
    Miller LW, Pagani FD, Russel SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885-896.PubMedCrossRefGoogle Scholar
  29. 29.
    Instructions for Use for Impella 2.5 Circulatory Support System. Abiomed, Inc. Danvers, MA. Available from: http://www.abiomed.com/products/documents/ImpellaIFU2-080046-9000_rC.pdf; 2008 Accessed 24.8.2008.
  30. 30.
    Tandem Heart PTVA system: guide to patient management. CardiaAssist, Inc. Pittsburgh, PA; 2006.Google Scholar
  31. 31.
    Conrad SA, Rycus PT, Dalton H. Extracorporeal Life Support Registry Report 2004. ASAIO J. 2005;51:4-10.PubMedCrossRefGoogle Scholar
  32. 32.
    Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure: a randomized prospective study. JAMA. 1979; 242:2193-2196.PubMedCrossRefGoogle Scholar
  33. 33.
    Morris AH, Wallace CJ, Menlove FL, et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med. 1994;149:295-305.PubMedGoogle Scholar
  34. 34.
    Hemmila MR, Rowe SA, Boules TN, et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg. 2004;240:595-607.PubMedGoogle Scholar
  35. 35.
    Peek GJ, Clemen F, Elbourne D, et al. CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Serv Res. 2006;6:163.PubMedCrossRefGoogle Scholar
  36. 36.
    Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomized controlled trial. Lancet 2009:374:1351–1363.PubMedCrossRefGoogle Scholar
  37. 37.
    Fischer S, Bohn D, Rycus P, et al. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: analysis of the Extracorporeal Life Support Organization (ELSO) registry. J Heart Lung Transplant. 2007;26:472-477.PubMedCrossRefGoogle Scholar
  38. 38.
    Chumnanvej S, Wood MJ, MacGillivray TE, et al. Perioperative echocardiographic examination for ventricular assist device implantation. Anesth Analg. 2007;105:583-601.PubMedCrossRefGoogle Scholar

Additional Reading

  1. Ferguson JJ, Cohen M, Freedman RJ, et al. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol. 2001;38:1456-1462.PubMedCrossRefGoogle Scholar
  2. Cohen M, Dawson MS, Kopinstansky C, McBride R. Sex and other predictors of intra-aortic balloon counterpulsation-related complications: prospective study of 1119 patients. Am Heart J. 2000;139:282-287.PubMedGoogle Scholar
  3. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.PubMedCrossRefGoogle Scholar
  4. Tsukui K, Abla A, Teuteberg JJ, et al. Cerebrovascular accidents in patients with a ventricular assist device. J Thor Cardiovasc Surg. 2007;134:114-123.CrossRefGoogle Scholar
  5. Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure: a randomized prospective study. JAMA. 1979;242:2193-2196.Google Scholar
  6. Peek GJ, Clemen F, Elbourne D, et al. CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Serv Res. 2006;6:163.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Scott A. Schartel
    • 1
  • Sheela S. Pai
    • 1
  1. 1.Department of AnesthesiologyTemple University School of MedicinePhiladelphiaUSA

Personalised recommendations